Basilar artery occlusion management: Specialist perspectives from an international survey.
Christopher EdwardsBrian DrummJames E SieglerWouter J SchonewillePiers KleinXiaochuan HuoYimin ChenMohamad AbdalKaderMuhammad M QureshiStrbian DanielXin-Feng LiuWei HuXunming JiChuanhui LiUrs FischerSimon NagelVolker PuetzPatrik MichelFana AlemsegedSimona SaccoHiroshi YamagamiShadi YaghiDavide StramboEspen Saxhaug KristoffersenElse Chartlotte SandsetRobert MikulíkGeorgios K TsivgoulisHesham E MasoudDiana Aguiar de SousaJoão Pedro MartoKyriakos LobotesisDylan RoiAnne BerberichJelle DemeestereThomas Raphael MeinelRodrigo RiveraSven PoliMai Duy TonYuyou ZhuFengli LiHongfei SangGötz ThomallaMark W ParsonsBruce C V CampbellOsama O ZaidatHui-Sheng ChenThalia Shoshana FieldJean RaymondJohannes KaesmacherRaul Gomes NogueiraTudor G JovinDapeng SunRaynald LiuAdnan I QureshiZhong Ming QiuZhongrong MiaoSoma BanerjeeThanh N NguyenPublished in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2023)
Following the publication of two neutral clinical trials in BAO EVT, most stroke providers believed EVT to be superior to medical management in carefully selected patients, with most indicating they would not randomize a BAO patient to medical treatment. There were small differences in preference for advanced neuroimaging for patient selection, although these preferences were unsupported by clinical trial data at the time of the survey.